Microarray profiling identifies extracellular circulating miRNAs dysregulated in cystic fibrosis

Area of Science:

• Biochemistry
• Genetics
• Molecular Biology

Background:

• Extracellular circulating microRNAs (ECmiRNAs) are vital for intercellular communication and are emerging biomarkers for various diseases.
• Their role and abundance in cystic fibrosis (CF) are not well understood.
• Investigating ECmiRNAs in CF can reveal novel insights into disease mechanisms and potential diagnostic tools.

Purpose of the Study:

• To identify differentially expressed plasma ECmiRNAs in CF patients compared to healthy controls.
• To elucidate the functional relevance of these ECmiRNAs and their predicted targets in CF.
• To explore the association of ECmiRNA targets with key signaling pathways implicated in CF.

Main Methods:

• Microarray technology was utilized to profile plasma ECmiRNAs in CF and healthy control (HC) samples.
• Bioinformatic tools were employed for in silico identification and network analysis of validated miRNA targets.
• Pathway enrichment analysis was performed to identify biological processes and signaling pathways affected by the identified targets.

Main Results:

• Eleven ECmiRNAs exhibited significant expression differences between CF and HC groups (FDR < 0.05, log2 FC ≥ 2).
• Ten ECmiRNAs were upregulated, and one (hsa-miR-598-3p) was downregulated in CF plasma.
• Network analysis highlighted hsa-let-7b-5p as a key hub, with targets like AGO1, DICER1, HMGA1, and MYC involved in miRNA biogenesis and gene expression.

Conclusions:

• Aberrantly expressed ECmiRNAs are present in the plasma of CF patients.
• These ECmiRNAs and their targets are implicated in crucial signaling pathways (e.g., PI3K/Akt, Wnt/β-catenin) relevant to CF pathogenesis.
• ECmiRNAs represent a promising area for further investigation as potential non-invasive biomarkers and therapeutic targets in CF.